PKU HealthCare (SZ:000788) Zhong Guo Zheng Quan Bao·2025-11-12 12:36Core Viewpoint - The chairman and president of Beijing University Pharmaceutical, Xu Xiren, has been arrested for suspected criminal activity, leading to temporary changes in leadership roles within the company [1][3]. Group 1: Company Leadership Changes - Xu Xiren has been arrested, and the board member Chen Yuezhong will act as chairman while the executive vice president Yu Mengchuan will assume the role of president and legal representative [1][3]. - The company confirms that there has been no change in control, and the board of directors is functioning normally [1][3]. Group 2: Company Background and Financial Performance - Beijing University Pharmaceutical, established in 1965, was listed on the Shenzhen Stock Exchange in 1997 and is now a member of the New Fangzheng Group controlled by China Ping An [4]. - The company specializes in drug research, production, and sales, recognized as a national innovative pilot enterprise and a key high-tech enterprise [4]. - For the first three quarters of 2023, the company reported revenue of 1.231 billion yuan, a year-on-year decrease of 19.76%, while net profit was 136 million yuan, an increase of 4.31% [4]. - As of November 12, 2023, the stock price was 6.68 yuan per share, with a market capitalization of 4 billion yuan [4].